Impact of anatomical changes on simulated proton arc therapy and intensity‐modulated proton therapy for lung cancer
Journal of Applied Clinical Medical Physics · 2026
DOI: 10.1002/acm2.70881 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Applied Clinical Medical Physics, 2026. Verfasst von Wenguang Chen und 10 weiteren Autor:innen. Beteiligte Einrichtung: Applied Nuclear Technology in Geosciences Key Laboratory of Sichuan Province, Chengdu University of Technology, Chengdu, China. Hauptthemen laut MEDLINE: Proton Therapy, Lung Neoplasms, Radiotherapy, Intensity-Modulated, Radiotherapy Planning, Computer-Assisted. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundamental Research Funds for the Central Universities, Health Commission of Sichuan Province Medical Science and Technology Program, National Science and Technology Major Project.
Abstract (Originalsprache)
Purpose
During lung cancer radiotherapy, inter‐fractional anatomical changes may cause the delivered dose to deviate from the primary plan, affecting tumor control and increasing the risk of normal tissue damage. This study aims to evaluate the impact of anatomical changes on the dosimetric and radiobiological performance of simulated proton arc therapy (sPAT) versus intensity‐modulated proton therapy (IMPT) for lung cancer patients under patient‐specific anatomical changes.
Methods
Data from 21 lung cancer patients were retrospectively analyzed. The prescribed dose for all patients was 6000 cGy (relative biological effectiveness, RBE). Each patient with a primary planning computed tomography (pCT) and a mid‐treatment adaptive‐planning CT (aCT) acquired at a median of 29 days into treatment due to notable tumor volume changes. Primary plans for sPAT and IMPT were designed on the pCT. After rigid registration of the pCT and aCT, non‐adaptive plans (sPAT p‐a , IMPT p‐a ) were generated by directly recalculating the doses of the primary plans on the aCT. The comparison evaluated the dosimetric impact of anatomical changes by comparing non‐adaptive plans (sPAT p‐a vs. IMPT p‐a ). Dose‐volume histogram (DVH) parameters for targets and organs at risk (OARs) and tumor control probability (TCP) and normal tissue complication probability (NTCP) were evaluated.
Results
For the primary plans, sPAT and IMPT achieved similar target coverage, while the doses to OARs were generally lower in sPAT p . Under anatomical changes, both non‐adaptive plans exhibited a decrease in target coverage, sPAT p‐a achieved a D 95% of 5567.57 cGy[RBE] compared with 5423.33 cGy[RBE] for IMPT p‐a ( p < 0.001), indicating that sPAT better preserved target coverage. Compared with the primary plans, sPAT p‐a and IMPT p‐a exhibited TCP reductions of 5.83% and 8.07%, respectively.
Conclusions
Compared with IMPT, sPAT exhibits enhanced robustness against inter‐fractional anatomical changes occurring in lung‐cancer radiotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Applied Nuclear Technology in Geosciences Key Laboratory of Sichuan Province, Chengdu University of Technology, Chengdu, China.
- Department of Radiation Oncology, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Ch…
- School of Physics, University of Electronic Science and Technology, Chengdu, China.
- Institute of Nuclear Science and Technology, Sichuan University, Chengdu, China.
- Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
- Department of Radiation Oncology, Corewell Health, William Beaumont University Hospital, Royal Oak, Michigan, USA.
ORCID-Profile: Wenguang Chen
Förderung
- Fundamental Research Funds for the Central Universities
- Health Commission of Sichuan Province Medical Science and Technology Program
- National Science and Technology Major Project
- National Natural Science Foundation of China Young Science Fund
Zitieren
APA
Chen, W., Yang, F., Zeng, F., Guo, H., Xu, Y., Zhang, T., Wu, J., Zhang, D., Liu, G., Ding, X., & Wang, X. (2026). Impact of anatomical changes on simulated proton arc therapy and intensity‐modulated proton therapy for lung cancer. Journal of Applied Clinical Medical Physics. https://doi.org/10.1002/acm2.70881
Vancouver
Chen W, Yang F, Zeng F, Guo H, Xu Y, Zhang T, et al. Impact of anatomical changes on simulated proton arc therapy and intensity‐modulated proton therapy for lung cancer. Journal of Applied Clinical Medical Physics. 2026. doi:10.1002/acm2.70881
BibTeX
@article{Chen2026,
author = {Chen, Wenguang and Yang, Feng and Zeng, Fanrui and Guo, Hao and Xu, Yuankang and Zhang, Tianyu and Wu, Junxiang and Zhang, Da and Liu, Gang and Ding, Xuanfeng and Wang, Xianliang},
title = {Impact of anatomical changes on simulated proton arc therapy and intensity‐modulated proton therapy for lung cancer},
journal = {Journal of Applied Clinical Medical Physics},
year = {2026},
doi = {10.1002/acm2.70881}
}
EUVIMED